GOT2 knockout did not affect the proliferation of pancreatic cancer cells in vitro and tumor progression in immunocompromised mouse models, but severely impaired xenograft growth in mice with intact immune systems. This evidence concerns the gene GOT2 and pancreatic neoplasm.